Aydogan M S, Bıçakcıoğlu M, Sayan H, Durmus M, Yılmaz S
Department of Anesthesiology and Reanimation, Inonu University, Faculty of Medicine, Malatya, Turkey.
Department of Anesthesiology and Reanimation, Inonu University, Faculty of Medicine, Malatya, Turkey.
Transplant Proc. 2015 May;47(4):1204-6. doi: 10.1016/j.transproceed.2014.09.184.
The aim of this study was the compare the donor patients who received intravenous (IV) morphine with patient-controlled analgesia (PCA) or epidural morphine during the early postoperative period who underwent liver transplantation. Forty patients were included in the study and randomly divided into 2 groups in a double-blinded manner. They were given IV morphine 5 mg (Group C), or epidural anesthesia adding morphine (2 mg; Group E) by epidural anesthesia technique starting 15 minutes before the estimated time of completion of surgery. All of the patients received PCA with IV morphine (Group C; PCA device was set to deliver 1 mg morphine with a lockout of 15 minutes and a 4-hour limit of 20 mg, and no continuous infusion) or epidural morphine (Group E; patient-controlled epidural analgesia [PCEA] device was set to deliver 0.5 mg morphine with a lockout of 30 minutes and a 4-hour limit of 10 mg, and no continuous infusion) and were followed up for 24 hours, and pain scores were evaluated by study nurses who were blinded to the study protocol. The visual analogue scale (VAS) scores at rest and at movement and morphine consumption at 12 and 24 hours after operation evaluation time points were significantly higher in Group E than those in Group C (P < .05). Furthermore, total morphine consumption in Group C was significantly higher than that in Group E (P < .05). Epidural morphine via PCEA was associated with decreased postoperative VAS scores and morphine consumption. These findings may be beneficial for managing postoperative analgesia protocols in liver transplant donor patients.
本研究的目的是比较肝移植术后早期接受静脉注射吗啡自控镇痛(PCA)或硬膜外吗啡的供体患者。40例患者纳入研究,并以双盲方式随机分为2组。在预计手术结束前15分钟开始,通过硬膜外麻醉技术,给他们静脉注射5毫克吗啡(C组),或硬膜外麻醉加吗啡(2毫克;E组)。所有患者均接受静脉注射吗啡的PCA(C组;PCA装置设置为每次注射1毫克吗啡,锁定时间为15分钟,4小时限量为20毫克,无持续输注)或硬膜外吗啡(E组;患者自控硬膜外镇痛[PCEA]装置设置为每次注射0.5毫克吗啡,锁定时间为30分钟,4小时限量为10毫克,无持续输注),并随访24小时,由对研究方案不知情的研究护士评估疼痛评分。术后评估时间点12小时和24小时时,E组静息和活动时的视觉模拟量表(VAS)评分及吗啡消耗量均显著高于C组(P<0.05)。此外,C组的吗啡总消耗量显著高于E组(P<0.05)。通过PCEA使用硬膜外吗啡可降低术后VAS评分和吗啡消耗量。这些发现可能有助于管理肝移植供体患者的术后镇痛方案。